F&S Pharmatech is Pharmaceuticals in China that focus on pharmaceutical intermediates business. Founded in 2015. They cover business area such as developer, differentiated generic drug, pharmaceutical intermediate, China, development, advanced pharmaceutical chemical, sacubitril, diphenyl piperidine methanol, reliable product, r&d center, product cost.
2015
( 9 years old in 2024 )
Pharmaceutical Intermediates
-
Building 2, Zifeng Research and Development Center
29 Buyue Road, Pukou Economic Development Zone
Nanjing, Jiangsu
China
Private
developerdifferentiated generic drugpharmaceutical intermediateChinadevelopmentadvanced pharmaceutical chemicalsacubitrildiphenyl piperidine methanolreliable productr&d centerproduct cost
* We use standard office opening hours in near F&S Pharmatech's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
F&S Pharmatech is Pharmaceuticals business from China that founded in 2015 (9 years old in 2024), F&S Pharmatech business is focusing on Pharmaceutical Intermediates.
F&S Pharmatech headquarter office and corporate office address is located in Building 2, Zifeng Research and Development Center 29 Buyue Road, Pukou Economic Development Zone Nanjing, Jiangsu China.
F&S Pharmatech was founded in China.
In 2024, F&S Pharmatech is currently focus on pharmaceutical intermediates sector.
Above is snippet of Google Trends for "pharmaceutical intermediates" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with F&S Pharmatech, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
